Beneficial effects of estrogen treatment in the HLA-B27 transgenic rat model of inflammatory bowel disease

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 286, Issue 1 49-1, 2004, Pages

  Harnish, Douglas C ^a,c   Albert, Leo M ^a   Leathurby, Yelena ^a   Eckert, Amy M ^a   Ciarletta, Agnes ^b   Kasaian, Marion ^b   Keith Jr , James C ^a  

^a PFIZER INC   (United States)

^b The Inflammation Research Foundation   (United States)

^c NONE   (United States)

Author keywords

Estrogen receptor; Mast cells

Indexed keywords

ANTIESTROGEN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; HLA B27 ANTIGEN; MAST CELL PROTEASE 1; MAST CELL PROTEASE 3; MAST CELL PROTEASE 4; MESSENGER RNA; MYELOPEROXIDASE; PROTEINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL ACTIVATION; CELL INFILTRATION; CHRONIC DIARRHEA; CONTROLLED STUDY; DISEASE SEVERITY; ENTERITIS; ENZYME ACTIVITY; GENE EXPRESSION; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INTESTINAL FIBROSIS; INTESTINE CELL; INTESTINE ULCER; MALE; MAST CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; TRANSGENIC MOUSE;

EID: 0347988213     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00024.2003     Document Type: Article

References (80)

1. An J, Ribeiro RC, Webb P, Gustafsson JA, Kushner PJ, Baxter JD, and Leitman DC. Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators. Proc Natl Acad Sci USA 96: 15161-15166, 1999.
2. Araki Y, Andoh A, Fujiyama Y, and Bamba T. Development of dextran sulphate sodium-induced experimental colitis is suppressed in genetically mast cell-deficient Ws/Ws rats. Clin Exp Immunol 119: 264-269, 2000.
3. Asako H, Kurose I, Wolf R, DeFrees S, Zheng ZL, Phillips ML, Paulson JC, and Granger DN. Role of H1 receptors and P-selectin in histamine-induced leukocyte rolling and adhesion in postcapillary venules. J Clin Invest 93: 1508-1515, 1994.
4. Auphan N, DiDonato JA, Rosette C, Helmberg A, and Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270: 286-290, 1995.
5. Badger AM, Blake SM, Dodds RA, Griswold DE, Swift BA, Rieman DJ, Stroup GB, Hoffman SJ, and Gowen M. Idoxifene, a novel selective estrogen receptor modulator, is effective in a rat model of adjuvant-induced arthritis. J Pharmacol Exp Ther 291: 1380-1386, 1999.
6. Bhat RA, Harnish DC, Stevis PE, Lyttle CR, and Komm BS. A novel human estrogen receptor beta: identification and functional analysis of additional N-terminal amino acids. J Steroid Biochem Mol Biol 67: 233-240, 1998.
7. Boughton-Smith NK, Wallace JL, Morris GP, and Whittle BJ. The effect of anti-inflammatory drugs on eicosanoid formation in a chronic model of inflammatory bowel disease in the rat. Br J Pharmacol 94: 65-72, 1988.
8. Boughton-Smith NK, Wallace JL, and Whittle BJ. Relationship between arachidonic acid metabolism, myeloperoxidase activity and leukocyte infiltration in a rat model of inflammatory bowel disease. Agents Actions 25: 115-123, 1988.
9. Breban M, Hammer RE, Richardson JA, and Taurog JD. Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment. J Exp Med 178: 1607-1616, 1993.
10. Campbell-Thompson M, Lynch IJ, and Bhardwaj B. Expression of estrogen receptor (ER) subtypes and ERβ isoforms in colon cancer. Cancer Res 61: 632-640 1999.
11. Campbell-Thompson ML. Estrogen receptor alpha and beta expression in upper gastrointestinal tract with regulation of trefoil factor family 2 mRNA levels in ovariectomized rats. Biochem Biophys Res Commun 240: 478-483, 1997.
12. Chin KW and Barrett KE. Mast cells are not essential to inflammation in murine model of colitis. Dig Dis Sci 39: 513-525, 1994.
13. Cowley SM, Hoare S, Mosselman S, and Parker MG. Estrogen receptors alpha and beta form heterodimers on DNA. J Biol Chem 272: 19858-19862, 1997.
14. Cuzzocrea S, Mazzon E, Sautebin L, Serraino I, Dugo L, Calabro G, Caputi AP, and Maggi A. The protective role of endogenous estrogens in carrageenan-induced lung injury in the rat. Mol Med 7: 478-487, 2001.
15. Deshpande R, Khalili H, Pergolizzi RG, Michael SD, and Chang MD. Estradiol downregulates LPS-induced cytokine production and NF-κB activation in murine macrophages. Am J Reprod Immunol 38: 46-54, 1997.
16. Dieleman LA, Ridwan BU, Tennyson GS, Beagley KW, Bucy RP, and Elson CO. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 107: 1643-1652, 1994.
17. Dvorak AM, Monahan RA, Osage JE, and Dickersin GR. Crohn's disease: transmission electron microscopic studies. II. Immunologic inflammatory response. Alterations of mast cells, basophils, eosinophils, and the microvasculature. Hum Pathol 11: 606-619, 1980.
18. Elson CO, Sartor RB, Tennyson GS, and Riddell RH. Experimental models of inflammatory bowel disease. Gastroenterology 109: 1344-1367, 1995.
19. Evans MJ, Eckert A, Lai K, Adelman SJ, and Harnish DC. Reciprocal antagonism between estrogen receptor and NF-kappa B activity in vivo. Circ Res 89: 823-830, 2001.
20. Evans MJ, Harris HA, Miller CP, Karathanasis SK, and Adelman SJ. Estrogen receptors alpha and beta have similar activities in multiple endothelial cell pathways. Endocrinology 143: 3785-3795, 2002.
21. Evans MJ, Lai K, Shaw LJ, Harnish DC, and Chadwick CC. Estrogen receptor alpha inhibits IL-1beta induction of gene expression in the mouse liver. Endocrinology 143: 2559-2570, 2002.
22. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115: 182-205, 1998.
23. Fujihara SM, Cleaveland JS, Grosmaire LS, Berry KK, Kennedy KA, Blake JJ, Loy J, Rankin BM, Ledbetter JA, and Nadler SG. A D-amino acid peptide inhibitor of NF-kappa B nuclear localization is efficacious in models of inflammatory disease. J Immunol 165: 1004-1012, 2000.
24. Fukumoto Y, Kasai H, Takahashi H, Sugiyama H, Hase N, Kaneko H, Hamamura I, Aoki Y, Ota M, Kobayashi T, Katsuura Y, Kamimura T, and Komoriya K. The role of mast cells in the development of 2,4,6-trinitrobenzene sulfonic acid-induced colitis in rats. Scand J Gastroenterol 37: 555-560, 2002.
25. Gelbmann CM, Mestermann S, Gross V, Kollinger M, Scholmerich J, and Falk W. Strictures in Crohn's disease are characterised by an accumulation of mast cells colocalised with laminin but not with fibronectin or vitronectin. Gut 45: 210-217, 1999.
26. Gordon JR, Burd PR, and Galli SJ. Mast cells as a source of multifunctional cytokines. Immunol Today 11: 458-464, 1990.
27. Haller D, Russo MP, Sartor RB, and Jobin C. IKK beta and phosphatidylinositol 3-kinase/Akt participate in non-pathogenic Gram-negative enteric bacteria-induced RelA phosphorylation and NF-kappa B activation in both primary and intestinal epithelial cell lines. J Biol Chem 277: 38168-38178, 2002.
28. Hammer RE, Maika SD, Richardson JA, Tang JP, and Taurog JD. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell 63: 1099-1112, 1990.
29. Harnish DC, Scicchitano MS, Adelman SJ, Lyttle CR, and Karathanasis SK. The role of CBP in estrogen receptor cross-talk with nuclear factor-kappaB in HepG2 cells. Endocrinology 141: 3403-3411, 2000.
30. Higa A, Ishikawa N, Eto T, and Nawa Y. Evaluation of the role of mast cells in the progression of acetic acid-induced colitis in mice. Scand J Gastroenterol 31: 774-777, 1996.
31. Jansson L and Holmdahl R. Enhancement of collagen-induced arthritis in female mice by estrogen receptor blockage. Arthritis Rheum 44: 2168-2175, 2001.
32. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, and Manolagas SC. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257: 88-91, 1992.
33. Kassi EN, Vlachoyiannopoulos PG, Moutsopoulos HM, Sekeris CE, and Moutsatsou P. Molecular analysis of estrogen receptor alpha and beta in lupus patients. Eur J Clin Invest 31: 86-93, 2001.
34. Kim MS, Chae HJ, Shin TY, Kim HM, and Kim HR. Estrogen regulates cytokine release in human mast cells. Immunopharmacol Immunotoxicol 23: 495-504, 2001.
35. Krawisz JE, Sharon P, and Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87: 1344-1350, 1984.
36. Krishnaswamy G, Kelley J, Johnson D, Youngberg G, Stone W, Huang SK, Bieber J, and Chi DS. The human mast cell: functions in physiology and disease. Front Biosci 6: D1109-D1127, 2001.
37. Lutzelschwab C, Lunderius C, Enerback L, and Hellman L. A kinetic analysis of the expression of mast cell protease mRNA in the intestines of Nippostrongylus brasiliensis-infected rats. Eur J Immunol 28: 3730-3737, 1998.
38. Minocha A, Thomas C, and Omar R. Lack of crucial role of mast cells in pathogenesis of experimental colitis in mice. Dig Dis Sci 40: 1757-1762, 1995.
39. Miyamoto N, Mandai M, Suzuma I, Suzuma K, Kobayashi K, and Honda Y. Estrogen protects against cellular infiltration by reducing the expressions of E-selectin and IL-6 in endotoxin-induced uveitis. J Immunol 163: 374-379, 1999.
40. Mogadam M, Korelitz BI, Ahmed SW, Dobbins WO 3rd, and Baiocco PJ. The course of inflammatory bowel disease during pregnancy and postpartum. Am J Gastroenterol 75: 265-269, 1981.
41. Mooradian AD. Antioxidant properties of steroids. J Steroid Biochem Mol Biol 45: 509-511, 1993.
42. Mullin JM and Snock KV. Effect of tumor necrosis factor on epithelial tight junctions and transepithelial permeability. Cancer Res 50: 2172-2176, 1990.
43. Nelson JL. Pregnancy immunology and autoimmune disease. J Reprod Med 43: 335-340, 1998.
44. Neurath MF, Becker C, and Barbulescu K. Role of NF-kappaB in immune and inflammatory responses in the gut. Gut 43: 856-860, 1998.
45. Neurath MF, Pettersson S, Meyer zum Buschenfelde KH, and Strober W. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med 2: 998-1004, 1996.
46. Nicovani S and Rudolph MI. Estrogen receptors in mast cells from arterial walls. Biocell 26: 15-24, 2002.
47. Nikolaus S, Folsen U, and Schreiber S. Immunopharmacology of 5-aminosalicylic acid and of glucocorticoids in the therapy of inflammatory bowel disease. Hepatogastroenterology 47: 71-82, 2000.
48. Nikolaus S, Raedler A, Kuhbacker T, Sfikas N, Folsch UR, and Schreiber S. Mechanisms in failure of infliximab for Crohn's disease. Lancet 356: 1475-1479, 2000.
49. Oda T. Role of mast cells in dextran sulfate sodium-induced experimental colitis in rats. J Kyoto Pref Univ Med 104: 1069-1082, 1995.
50. Pace P, Taylor J, Suntharalingam S, Coombes RC, and Ali S. Human estrogen receptor beta binds DNA in a manner similar to and dimerizes with estrogen receptor alpha. J Biol Chem 272: 25832-25838, 1997.
51. Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18: 6853-6866, 1999.
52. Pang X, Cotreau-Bibbo MM, Sant GR, and Theoharides TC. Bladder mast cell expression of high affinity oestrogen receptors in patients with interstitial cystitis. Br J Urol 75: 154-161, 1995.
53. Pelzer T, Neumann M, de Jager T, Jazbutyte V, and Neyses L. Estrogen effects in the myocardium: inhibition of NF-kappaB DNA binding by estrogen receptor-alpha and -beta. Biochem Biophys Res Commun 286: 1153-1157, 2001.
54. Peterson RL, Wang L, Albert L, Keith JC Jr, and Dorner AJ. Molecular effects of recombinant human interleukin-11 in the HLA-B27 rat model of inflammatory bowel disease. Lab Invest 78: 1503-1512, 1998.
55. Pottratz ST, Bellido T, Mocharla H, Crabb D, and Manolagas SC. 17 beta-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. J Clin Invest 93: 944-950, 1994.
56. Ray A, Prefontaine KE, and Ray P. Down-modulation of interleukin-6 gene expression by 17 beta-estradiol in the absence of high affinity DNA binding by the estrogen receptor. J Biol Chem 269: 12940-12946, 1994.
57. Ray P, Ghosh SK, Zhang DH, and Ray A. Repression of interleukin-6 gene expression by 17 beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor. FEBS Lett 409: 79-85, 1997.
58. Reinecker HC, Steffen M, Witthoeft T, Pflueger I, Schreiber S, MacDermott RP, and Raedler A. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 94: 174-181, 1993.
59. Rider V and Abdou NI. Gender differences in autoimmunity: molecular basis for estrogen effects in systemic lupus erythematosus. Int Immunopharmacol 1: 1009-1024, 2001.
60. Rodriguez P, Heyman M, Candalh C, Blaton MA, and Bouchaud C. Tumour necrosis factor-alpha induces morphological and functional alterations of intestinal HT29 cl.19A cell monolayers. Cytokine 7: 441-448, 1995.
61. Rogler G, Brand K, Vogl D, Page S, Hofmeister R, Andus T, Knuechel R, Baeuerle PA, Scholmerich J, and Gross V. Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 115: 357-369, 1998.
62. Scheinman RI, Cogswell PC, Lofquist AK, and Baldwin AS Jr. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 270: 283-286, 1995.
63. Schreiber S, Nikolaus S, and Hampe J. Activation of nuclear factor kappa B inflammatory bowel disease. Gut 42: 477-484, 1998.
64. Scudamore CL, Thornton EM, McMillan L, Newlands GF, and Miller HR. Release of the mucosal mast cell granule chymase, rat mast cell protease-II, during anaphylaxis is associated with the rapid development of paracellular permeability to macromolecules in rat jejunum. J Exp Med 182: 1871-1881, 1995.
65. Speir E, Yu ZX, Takeda K, Ferrans VJ, and Cannon RO. Competition for p300 regulates transcription by estrogen receptors and nuclear factor-kappa B in human coronary smooth muscle cells. Circ Res 87: 1006-1011, 2000.
66. Stein B and Yang MX. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. Mol Cell Biol 15: 4971-4979, 1995.
67. Stein J, Ries J, and Barrett KE. Disruption of intestinal barrier function associated with experimental colitis: possible role of mast cells. Am J Physiol Gastrointest Liver Physiol 274: G203-G209, 1998.
68. Stenton GR, Vliagoftis H, and Befus AD. Role of intestinal mast cells in modulating gastrointestinal pathophysiology. Ann Allergy Asthma Immunol 81: 1-11, 1998.
69. Sun WH, Keller ET, Stebler BS, and Ershler WB. Estrogen inhibits phorbol ester-induced I kappa B alpha transcription and protein degradation. Biochem Biophys Res Commun 244: 691-695, 1998.
70. Talley NJ and Butterfield JH. Mast cell infiltration and degranulation in colonic mucosa in the irritable bowel syndrome. Am J Gastroenterol 91: 1675-1676, 1996.
71. Tannenbaum S, Oertel H, Henderson W, and Kaliner M. The biologic activity of mast cell granules. I. Elicitation of inflammatory responses in rat skin. J Immunol 125: 325-335, 1980.
72. Tornwall J, Carey AB, Fox RI, and Fox HS. Estrogen in autoimmunity: expression of estrogen receptors in thymic and autoimmune T cells. J Gend Specif Med 2: 33-40, 1999.
73. Tyree CM, Zou A, and Allegretto EA. 17beta-Estradiol inhibits cytokine induction of the human E-selectin promoter. J Steroid Biochem Mol Biol 80: 291-297, 2002.
74. Verdu EF, Deng Y, Bercik P, and Collins SM. Modulatory effects of estrogen in two murine models of experimental colitis. Am J Physiol Gastrointest Liver Physiol 283: G27-G36, 2002.
75. Wershil BK, Furuta GT, Wang ZS, and Galli SJ. Mast cell-dependent neutrophil and mononuclear cell recruitment in immunoglobulin E-induced gastric reactions in mice. Gastroenterology 110: 1482-1490, 1996.
76. Wilder RL. Hormones, pregnancy, and autoimmune diseases. Ann NY Acad Sci 840: 45-50, 1998.
77. Xu X, Weksler-Zangen S, Pikarsky A, Pappo O, Wengrower D, Bischoff SC, Pines M, Rivkind A, Goldin E, and Levi-Schaffer F. Mast cells involvement in the inflammation and fibrosis development of the TNBS-induced rat model of colitis. Scand J Gastroenterol 37: 330-337, 2002.
78. Yamagata K, Tanaka M, and Kudo II. A quantitative immunohistochemical evaluation of inflammatory cells at the affected and unaffected sites of inflammatory bowel disease. J Gastroenterol Hepatol 13: 801-808, 1998.
79. Zang YC, Halder JB, Hong J, Rivera VM, and Zhang JZ. Regulatory effects of estriol on T cell migration and cytokine profile: inhibition of transcription factor NF-kappa B. J Neuroimmunol 124: 106-114, 2002.
80. Zhao XJ, McKerr G, Dong Z, Higgins CA, Carson J, Yang ZQ, and Hannigan BM. Expression of oestrogen and progesterone receptors by mast cells alone, but not lymphocytes, macrophages or other immune cells in human upper airways. Thorax 56: 205-211, 2001.